Earnings ·
Reports Q1 FY2027 EPS of $2.92 and declares $0.66 quarterly dividend
RMDResmed Inc
ResMed reported first-quarter fiscal year 2027 results with revenue increasing 6% to $1.4 billion, up 7% on a core constant currency basis. GAAP diluted earnings per share rose 23% to $2.92, while non-GAAP diluted EPS increased 14% to $2.91. The company closed its previously announced divestiture of the MatrixCare business and returned more than $1.0 billion to shareholders through repurchases and dividends during the quarter. Additionally, ResMed declared a quarterly cash dividend of $0.66 per share with a record date of November 12, 2026, payable on December 17, 2026. The company develops sleep and breathing health technologies.